市場調査レポート

アジアのワクチン市場

Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia

発行 Kalorama Information 商品コード 180318
出版日 ページ情報 英文 180 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
アジアのワクチン市場 Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia
出版日: 2011年03月25日 ページ情報: 英文 180 Pages
概要

アジアのワクチン市場はその人口に比して規模は小さく、今なお成長を続けています。医薬品製造業者は次第にこの新興のワクチン市場での売上拡大に注目しています。アジアは世界人口のおよそ半数となる40億人を有しており、現在は西欧市場がワクチン市場を牽引しているものの、今後はアジアへの投資が続いていくでしょう。

当レポートでは、アジアの小児用、成人用予防ワクチン市場のそれぞれの規模、アジアの各国別市場動向、主要製造業者のシェアとプロファイル、法規制動向などをまとめ、概略以下の内容でお届けいたします。

エグゼクティブサマリー

ワクチンのイントロダクション

  • ワクチンと免疫反応
  • 作用機序
  • ワクチンの種類
  • アジア市場におけるワクチンの発展
  • ワクチン認可プロセス

小児用予防ワクチン

  • イントロダクション
  • 小児用ワクチン製品
  • 開発中の小児用ワクチン
  • アジアの小児用予防ワクチン市場

成人用予防ワクチン

  • イントロダクション
  • 成人用ワクチンで予防できる疾患
  • 世界のインフルエンザ監視プログラム
  • 成人の予防接種の推奨
  • 成人用ワクチン製品
  • 開発中の成人用ワクチン
  • アジアの成人用予防ワクチン市場

ワクチン市場サマリー

  • ワクチン市場を牽引する動向
  • 市場規模と予測

課題と動向

  • アジア太平洋地域の法規制構造の変化
  • 世界の予防接種動向
  • 知的財産権の問題
  • ワクチンの安全性
  • 製造業者の戦略
  • 製造業者のリスクと市場阻害因子
  • ワクチン不足
  • パンデミックの予防
  • ワクチンとバイオテロリズム
  • DNAワクチン接種
  • ワクチンデリバリーシステムの技術革新
  • ワクチン製造の技術革新
  • 予防接種スケジュールの変更と推奨

企業プロファイル

企業ディレクトリ

図表

目次
Product Code: KLI6205711

Abstract

The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets. The population of nearly 4 billion people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn' t stopped companies from investing in Asian vaccine markets.

The graying of the population in Asia and the growth in some regions such as India and China are primary indicators of the potential for vaccine markets. This has encouraged market participants to increase spending in research and development and distribution facilities in Asian countries. This report examines the market for vaccines used in humans for various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

As part of its coverage, this report includes:

  • Estimated Market Sizes for Pediatric Preventive Vaccines by Type in Asia (Influenz, Hepatitis, HPV, Pneumococcal, Combinations, Other Childhood Diseases)
  • Estimated Market Sizes for Adult Preventive Vaccines by Type in Asia (Influenza, Hepatitis, HPV, Travel and Endemic, Others) 2006 - 2014
  • Total Vaccine Market and Projections for Asian Countries: India, China, Japan, Korea, Indonesia and Rest of Asia
  • Major Manufacturers' Shares of the Asian Adult and Pediatric Vaccine Market, 2010
  • Profiles of Top Participating Companies
  • Discussion of Regulatory Trends and IP Trends
  • Disease Statistics and Government Immunization Information
  • Manufacturer Strategies in Asian Countries
  • Discussion of Current and Emerging Delivery Options Systems

Key issues in the global vaccine market today include product safety, refusal to immunize, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine-preventable diseases and their resulting deaths are now rare in the developed world. However, developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues such as vaccine safety, shortages and bioterrorism continue to weigh upon the industry.

The following companies are profiled in this report:

  • Bavarian Nordic A/S
  • Baxter International
  • Crucell
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Pfizer Inc
  • Sanofi Pasteur
  • Sinovac Biotech, Ltd

For the purpose of this report, secondary research into company reports, medical journals, trade publications and government reports was combined with primary research interviews of executives in the industry. In addition to this report, Kalorama has published research on the European vaccine industry and a look at what vaccines are in the pipeline in the future. Please see our website, www.kaloramainformation.com for more details on these studies.

Table of Contents

EXECUTIVE SUMMARY

  • THE ASIAN VACCINES MARKET
  • Scope and Methodology
  • Vaccine Overview
    • Pediatric Preventative Vaccines
    • Adult Preventative Vaccines
  • Total Market
  • Issues and Trends

INTRODUCTION TO VACCINES

  • Vaccines and The Immune Response
  • Mechanism of Action
  • Types of Vaccines
    • Attenuated (Weakened) Live Viruses
    • Killed (Inactivated) Viruses
    • Toxoid Vaccines
    • Genetically Engineered/Modified Vaccines
      • Subunit Vaccines
      • Conjugate Vaccines
      • DNA Vaccination
  • Development of Vaccines in Asian Markets
  • Vaccine Approval Process

PEDIATRIC PREVENTIVE VACCINES

  • Introduction
    • Vaccine Coverage Rates by Country
      • China
      • India
      • Japan
    • United Nations Initiatives
  • Pediatric Vaccine Products
    • BCG
    • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
      • Diphtheria
      • Pertussis
      • Tetanus
      • Hepatitis B
      • Poliomyelitis
    • Haemophilus Influenzae Type B
    • Hepatitis A
    • Human papillomavirus (HPV) vaccination
      • Gardasil
      • Cervarix
    • Measles, Mumps and Rubella
      • Measles
      • Mumps
      • Rubella
    • Meningococcal Disease
    • Pneumococcal Conjugate
    • Rotavirus
    • Varicella
  • Pediatric Vaccines in Development
  • The Asian Market for Pediatric Preventive Vaccines
    • Total Asian Market Size and Forecast
    • Asian Market by Product Type
      • Influenza
      • Hepatitis A & B
      • HPV
      • Childhood Vaccines
        • Pneumococcal
        • Combinations
        • Other Childhood Vaccines
      • Others
    • Major Manufacturer' s Market Share - Pediatric Vaccines

ADULT PREVENTIVE VACCINES

  • Introduction
  • Adult Vaccine-Preventable Diseases: Facts and Figures
  • Global Influenza Surveillance Program
  • Recommendations for Adult Immunizations
    • WHO International Health Regulations
  • Adult Vaccine Products
    • BCG
    • Cholera
    • Diphtheria-Tetanus
    • Hepatitis
      • Hepatitis A
      • Hepatitis B
    • Human Papilloma Virus (HPV)
      • Gardasil
      • Cervarix
    • Influenza
      • Pandemic Influenza
        • Avian Flu
        • Swine Flu
    • Japanese Encephalitis
    • Meningitis
    • Pneumococcal Disease
    • Rabies
    • Typhoid Fever
    • Yellow Fever
  • Adult Vaccines in Development
  • The Asian Market for Adult Preventive Vaccines
    • Total Asian Market Size and Forecast
    • Asian Market by Product Type
      • Influenza
      • Hepatitis
      • HPV
      • Travel/Endemic Vaccines
      • Others
    • Major Manufacturer' s Market Share - Adult Vaccines

VACCINES MARKET SUMMARY

  • Trends Driving the Vaccines Market
  • Market Size and Forecast
    • Vaccine Sales by Region
    • Vaccine Market Competitors

ISSUES AND TRENDS

  • Changes in the Regulatory Structure in Asia-Pacific
  • Global Immunization Trends
  • Intellectual Property Concerns
  • Vaccine Safety
    • Refusal to Immunize
    • Obesity
    • World Health Organization
    • The Future of Vaccine Safety
  • Manufacturer Strategies
    • Acquisitions and Alliances
    • Access to Medicine Programs
    • Global Expansion
  • Manufacturer Risks and Market Inhibitors
    • Investment Risk in Emerging Growth Markets
    • Investment Risks for Domestic Chinese Companies
    • Equitable pricing
  • Vaccine Shortages
    • Influenza Vaccine Manufacturing Difficulties
    • Financial incentives
    • Preventing Shortages in Developing Nations
      • Vaccine Bonds
  • Preventing Pandemics
  • Vaccines and Bioterrorism
    • Overview
    • Smallpox
    • Tularemia
    • Viral Hemorrhagic Fevers
  • DNA Vaccination
  • Innovations in Vaccine Delivery Systems
    • Edible Vaccines
    • Mucosal Delivery
    • Intranasal Delivery
    • Vaccine Patches
    • Vaccine Microneedle Chips
  • Innovations in Vaccine Production
    • Plant-Based Production
    • Insects
    • Nanoparticle Systems
  • Variations in Vaccination Schedules and Recommendations

COMPANY PROFILES

  • Bavarian Nordic A/S
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Baxter International
    • History and Lines of Business
    • Vaccine Products
    • Financial Information
  • Crucell
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Emergent Biosolutions
    • History and Lines of Business
    • Strategic Acquisition and Alliance
    • Vaccine Products
    • Financial
  • GlaxoSmithKline
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Merck
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Novartis
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Pfizer Inc
    • History and Lines of Business
    • Vaccine Products
    • Financial Information
  • Sanofi Pasteur
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Sinovac Biotech, Ltd
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information

COMPANY DIRECTORY

List of Exhibits

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: Estimated Market Sizes for Preventive Vaccines by Target Age Group in Asia 2006 - 2014
  • Figure 1-1: Estimated Market Sizes for Preventive Vaccines in Asian 2006 - 2014 Issues and Trends

CHAPTER TWO: INTRODUCTION TO VACCINES

  • Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2009 (United States)
  • Table 2-2: Changes in Preventable Disease Incidence, Japan AnnualIncidence 1985 vs 2008
  • Table 2-3: Vaccine-Preventable Diseases, June 2010
  • Table 2-4: Vaccine Research Trials by Region
  • Figure 2-1: SFDA Drug Approval and Production Approval Processes

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

  • Table 3-1: Global Immunization Rates by Vaccine Type 2008
  • Table 3-2: China Immunization Rates by Vaccine Type 1985 and 2008
  • Table 3-3: India Immunization Rates by Vaccine Type 1985 and 2008
  • Table 3-4: Japan Immunization Rates by Vaccine Type 1985 and 2008
  • Table 3-5: Selected Pediatric Vaccines in Development
  • Table 3-6: Estimated Market Sizes for Pediatric Preventive Vaccines in Asia 2006 - 2014
  • Table 3-1: Estimated Market Sizes for Pediatric Preventive Vaccines inAsia 2006 - 2014
  • Table 3-7: Estimated Market Sizes for Pediatric Preventive Vaccines by Type in Asia 2006 - 2014
  • Figure 3-2: Estimated Market Sizes for Pediatric Preventive Vaccines by Type in Asia, by Percent, 2010
  • Table 3-8: Major Manufacturers' Shares of the Pediatric Asian Preventive Vaccine Market, 2010
  • Figure 3-3: 2010 Asian Pediatric Vaccines Market Share, by Leading Competitors

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

  • Table 4-1: Recommended Universal Adult Immunization Schedule 2010
  • Table 4-2: Recommended Adult Immunization Schedule for Populations with Special Medical Conditions, 2010
  • Table 4-3: WHO Pandemic Classification Schedule
  • Table 4-4: Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO
  • Table 4-5: Risk for Japanese Encephalitis, by Country1
  • Table 4-6: Yellow Fever Vaccination Requirements for Travelers to Selected Asian Countries
  • Table 4-7: Selected Adult Preventive Vaccines in Development, 2010 Selected Adult Preventive Vaccines in Development, 2010
  • Table 4-8: Estimated Market Sizes for Adult Preventive Vaccinesin Asia 2006 - 2014
  • Figure 4-1: Estimated Market Sizes for Adult Preventive Vaccines in Asia 2006 - 2014
  • Table 4-9: Estimated Market Sizes for Adult Preventive Vaccines by Type in Asia 2006 - 2014
  • Figure 4-2: Estimated Market Sizes for Adult Preventive Vaccines by Typein Asia, by Percent, 2010
  • Table 4-10: Major Manufacturers' Shares of the Adult Asian Preventive Vaccine Market, 2010
  • Figure 4-3: 2010 Asian Adult Vaccines Market Share, byLeading Competitors

CHAPTER FIVE: VACCINES MARKET SUMMARY

  • Table 5-1: Estimated Market Sizes for Preventive Vaccines by Target Age Group in Asia 2006 - 2014
  • Table 5-1: Estimated Market Sizes for Preventive Vaccines in Asian 2006 - 2014 111
  • Figure 5-2: Asian Market for Vaccines Share by Type, 2006, 2010 and 2014
  • Table 5-2: Estimated Market Sizes for Adult and Pediatric Preventive Vaccines by Asian Region (Japan, China, India, Rest of Asia) 2006 - 2014
  • Figure 5-3 : Estimated Market Sizes for Adult and Pediatric Preventive Vaccines by Asian Region (Japan, China, India, Rest of Asia) 2006 - 2014
  • Figure 5-4: Estimated Market Sizes for Adult and Pediatric Preventive Vaccines by Asian Region, by Percent, 2010
  • Table 5-3: Major Manufacturers' Shares of the Total Asian Preventive Vaccine Market, 2010
  • Figure 5-5: 2010 Asian Vaccines Market Share, by Leading Competitors

CHAPTER SIX: ISSUES AND TRENDS

  • Table 6-1: United Nations Children' s Fund (UNICEF) Indicative Budget Pricing Table for Major Antigens, 2010
  • Table 6-2: Vaccination Schedules by Selected Country
Back to Top